Production (Stage)
U
Medicus Pharma Ltd. MDCX.V
TSX
Recommendation
Prev Close
$5.69
Volume
--
Avg Vol (90D)
257
Market Cap
$32.37M
Dividend & Yield
--
52-Week Range
$2.55 - $7.60
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Medicus Pharma appoints KPMG as new auditor, expands global clinical programs
6/6/2025 - Proactive Investors - UK
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering MDCX Stock News
6/2/2025 - GuruFocus
Medicus Pharma Secures $7 Million for Cancer Treatment Trials
6/2/2025 - TipRanks Financial Blog
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
6/2/2025 - Newsfile Corp. - News Releases
Medicus Pharma (NASDAQ:MDCX) Upgraded at Wall Street Zen
5/31/2025 - MarketBeat
Small cap wrap: ReconAfrica, Charbone Hydrogen, Medicus Pharma....
5/30/2025 - Proactive Investors - UK
D. Boral Capital Reiterates "Buy" Rating for Medicus Pharma (NASDAQ:MDCX)
5/30/2025 - MarketBeat
Medicus Pharma unveils pricing of $7M public offering
5/30/2025 - Proactive Investors - UK
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
5/30/2025 - Globe Newswire
Medicus Pharma prices $7 million share offering
5/30/2025 - SeekingAlpha.com: All News
Medicus Pharma prices $7 million share offering
5/30/2025 - Seeking Alpha - Healthcare
Medicus Pharma Ltd. Launches $7 Million Public Offering to Advance Cancer Treatment Trials
5/30/2025 - TipRanks Financial Blog
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering MDCX Stock News
5/30/2025 - GuruFocus
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering
5/30/2025 - Newsfile Corp. - News Releases
Medicus Pharma (MDCX) Stock Rating and Price Target Update MDCX Stock News
5/29/2025 - GuruFocus
D. Boral Capital Reiterates "Buy" Rating for Medicus Pharma (NASDAQ:MDCX)
5/29/2025 - Ticker Report
Medicus Pharma begins UAE cancer trial expansion ICYMI
5/25/2025 - Proactive Investors - UK
Medicus Pharma's (MDCX) Buy Rating Reaffirmed at D. Boral Capital
5/24/2025 - MarketBeat
Medicus Pharma (NASDAQ:MDCX) Rating Lowered to Sell at Wall Street Zen
5/24/2025 - Ticker Report
Insider Selling: Medicus Pharma Ltd. (NASDAQ:MDCX) Major Shareholder Sells 75,000 Shares of Stock
5/23/2025 - Ticker Report
Small cap wrap: Nextech3D.ai, Medicus Pharma, Synchronoss, ReconAfrica...
5/22/2025 - Proactive Investors - UK
Medicus Pharma receives UAE approval to begin Phase 2 study for non-invasive BCC treatment
5/22/2025 - Proactive Investors - UK
Medicus Pharma gets UAE approval for Phase 2 study for skin cancer therapy
5/22/2025 - Proactive Investors - UK
Medicus Pharma (MDCX) Receives 'Buy' Rating from D. Boral Capital MDCX Stock News
5/22/2025 - GuruFocus
Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) ...
5/22/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
--
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
45.90%
Year to Date Total Return
44.05%
1-Year Total Return
58.94%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Nov 21, 2024 - $2.55
52-week High
Oct 07, 2024 - $7.60
Valuation
Market Cap
$32.37M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
medicuspharma.com
Phone Number
Address
One First Canadian Place
Suite 3400 - 100 King Street West
Toronto, ON M5X 1A4
Country
Canada
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Medicus Pharma Ltd., a biotech/life sciences company, focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops SkinJect, with an... more